据Gen咨询公司称, the global digital therapeutics market is set to achieve an incremental growth of USD 8 十亿, 复合年增长率几乎达到 18.7% 在预测期内 2022-2028.

该行业报告提供了全球市场的市场预测, 接下来是对应用的详细分析, 最终用户, 和地区. The global market data on digital therapeutics can be segmented by application: 心血管疾病 (CVD), central nervous system (CNS) diseases, diabetes, obesity, respiratory diseases, smoking cessation, 其他的. Digital therapeutics market is further segmented by end user: employers, 患者, 付款人, providers, 其他的. 根据地区, the digital therapeutics market is segmented into: 北美, 欧洲, 亚太, 世界其他地区.

The global digital therapeutics market is highly competitive. Some of the leading companies operating in the market are 2Morrow Inc., Canary Health Inc., FITBIT Inc., NOOM INC., Omada Health Inc., Pear Therapeutics Inc., Propeller Health (ResMed Inc.), Teladoc Health Inc., TrialCard Incorporated, Twill Inc., Welldoc Inc.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
– Get a detailed picture of the Global Digital Therapeutics Market
– Identify segments/areas to invest in over the forecast period in the Global Digital Therapeutics Market
– 了解竞争环境, 市场的领先参与者
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.